Current role
Biotechnology · Healthcare
Chief Accounting Officer
2020-01-08–present
Charles Ence
Chief Accounting Officer
Relmada Therapeutics, Inc. (RLMD)Equibles does not estimate personal net worth.
Get an email with a short summary when Relmada Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RLMD alertsAbout Charles Ence
Charles Ence is recorded as Chief Accounting Officer at Relmada Therapeutics, Inc. (RLMD) since January 8, 2020. Relmada Therapeutics, Inc. reported in an 8-K filed December 15, 2025 that Charles Ence was appointed Chief Accounting and Compliance Officer, effective January 1, 2025. Relmada Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relmada Therapeutics, Inc. includes Sergio Traversa (CEO and Board Member), Charles J. Casamento (Chairman and Board Member), Maged Shenouda (CFO) and 3 others.
“I am pleased to offer you the position of Chief Accounting and Compliance Officer.”
Affiliation history
-
Current
2020-01-08–present
-
Relmada Therapeutics, Inc. (RLMD)
Proxy statement
CurrentStart not stated–present
Last confirmed April 17, 2026
-
Start not stated–2020-01-09
Company network
Leadership on record at Relmada Therapeutics, Inc.
- Sergio Traversa CEO, Board Member
- Charles J. Casamento Chairman, Board Member
- Maged Shenouda CFO
- Paul Kelly COO, Board Member
- Fabiana Fedeli Board Member
- John Glasspool Board Member